SCHEMBL29401241

SCHEMBL29401241

O=c1oc2cc(O)ccc2c2ccccc12

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 2/20 1.00
RXFP1 Q9HBX9 2/20 1.00
PDE2A O00408 1/20 0.79
PKLR P30613 1/20 0.69
MAOA P21397 2/20 0.64
MAPT P10636 4/20 0.62
LMNA P02545 4/20 0.61
KDM4E B2RXH2 3/20 0.61
ALDH1A1 P00352 3/20 0.61
ALOX15 P16050 1/20 0.61
HTT P42858 1/20 0.61
SMN1; SMN2 Q16637 1/20 0.61
HSD17B10 Q99714 1/20 0.61
HSD17B3 P37058 1/20 0.61
PPARG P37231 1/20 0.58
NCOA2 Q15596 1/20 0.58
NCOR2 Q9Y618 1/20 0.58
L3MBTL1 Q9Y468 1/20 0.58
CDK5 Q00535 2/20 0.57
CDK5R1 Q15078 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29369247 1.00 NPSR1 (1.00) NPSR1RXFP1PDE2APKLRMAOA
SCHEMBL4420540 1.00 NPSR1 (1.00) NPSR1RXFP1PDE2APKLRMAOA
Hydrochloric Acid SCHEMBL30777912 0.98 NPSR1 (0.96) NPSR1RXFP1PDE2APKLRMAOA
SCHEMBL29401099 0.89 PDE2A (1.00) NPSR1RXFP1PDE2APKLRMAOA
SCHEMBL29368885 0.89 PDE2A (1.00) NPSR1RXFP1PDE2APKLRMAOA
SCHEMBL803408 0.89 PDE2A (1.00) NPSR1RXFP1PDE2APKLRMAOA
SCHEMBL16663940 0.89 PDE2A (0.85) NPSR1RXFP1PDE2APKLRMAOA
SCHEMBL24922443 0.87 NPSR1 (0.77) NPSR1RXFP1PDE2APKLRMAOA
SCHEMBL31408197 0.87 NPSR1 (0.77) NPSR1RXFP1PDE2APKLRMAOA
SCHEMBL29466712 0.87 NPSR1 (0.77) NPSR1RXFP1PDE2APKLRMAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022040321-A1 PROTECTION AGAINST CORONAVIRUS INFECTION BY EXTRACTS AND EXTRACT COMPONENTS NATREON, INC. (US) 2022-02-24 WO claimed
WO-2025264805-A2 SYNBIOTICS FOR MODULATING GUT MICROFLORA POPULATIONS, TREATMENT OF DYSBIOSIS AND DISEASE PREVENTION, AND METHODS FOR MAKING AND USING SAME PERSEPHONE BIOSCIENCES, INC. (US) 2025-12-26 WO disclosed
CN-119110798-A Fluorine-containing ether compound, lubricant for magnetic recording medium, and magnetic recording medium 株式会社力森诺科 2024-12-10 CN disclosed
EP-4284781-A1 UROLITHIN DERIVATIVES AND METHODS OF USE THEREOF Vandria SA (CH) 2023-12-06 EP disclosed
CN-117015530-A Urolithin derivatives and methods of use thereof 范徳利亚股份公司 2023-11-07 CN disclosed
EP-4065103-A1 DIRECT AMPK ACTIVATOR COMPOUNDS COMBINED WITH INDIRECT AMPK ACTIVATOR COMPOUNDS, COMPOSITIONS, METHODS AND USES THEREOF Société des Produits Nestlé S.A. (CH) 2022-10-05 EP disclosed
WO-2022162471-A1 UROLITHIN DERIVATIVES AND METHODS OF USE THEREOF VANDRIA SA (CH) 2022-08-04 WO disclosed
WO-2022040321-A1 PROTECTION AGAINST CORONAVIRUS INFECTION BY EXTRACTS AND EXTRACT COMPONENTS NATREON, INC. (US) 2022-02-24 WO disclosed